Literature DB >> 19291390

Alpha2-adrenergic impact on hypothalamic magnocellular oxytocinergic neurons in long evans and brattleboro rats: effects of agonist and antagonists.

Jana Bundzikova1, Zdeno Pirnik, Dora Zelena, Jens D Mikkelsen, Alexander Kiss.   

Abstract

We have previously demonstrated that alpha2-adrenoceptors regulate hypothalamic magnocellular oxytocinergic (OXY) neurons in Sprague Dawley rats. Here we investigated whether activation/inhibition of alpha2-adrenoceptors may similarly trigger/downregulate the activity of OXY neurons in control Long Evans (+/+) and permanently osmotically stressed Brattleboro (di/di) rats. The effect of alpha2-adrenoceptor agonist, xylazine (XYL) and alpha2-adrenoceptor antagonists, atipamezole (ATIP), and idazoxan (IDX) were evaluated in the supraoptic (SON) and paraventricular (PVN) hypothalamic nuclei. Saline (SAL, 0.1 ml/100 g), XYL (10 mg/kg), ATIP, (1 mg/kg), and IDX (10 mg/kg) and IDX or ATIP followed by XYL were applied intraperitoneally. Rats were sacrificed 90 min later and Fos/OXY co-labelings analyzed in microscope. In control +/+ rats no or few Fos/OXY co-labelings occurred in SON and PVN. XYL significantly increased Fos incidence in OXY neurons in both nuclei. ATIP significantly suppressed the effect of XYL in both nuclei and IDX only in SON. In di/di controls 81% of OXY neurons in SON and 44% in PVN revealed Fos presence and XYL did not further elevate Fos number in SON OXY neurons and slightly increased Fos number in PVN. ATIP or IDX only partially reduced Fos in SAL or XYL treated di/di rats. Our data indicate that: (1) XYL stimulation is not effective in di/di rats because of sustained upregulation of OXY neurons activity and (2) neither ATIP nor IDX reduced significantly the OXY activity in control di/di rats. These findings suggest that alpha2-adrenoceptors have only a limited impact in maintaining OXY cells activity upregulation in PVN and SON of di/di rats.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19291390     DOI: 10.1007/s10571-009-9388-0

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  49 in total

1.  Involvement of medullary A2 noradrenergic neurons in the activation of oxytocin neurons after conditioned fear stimuli.

Authors:  Lingling Zhu; Tatsushi Onaka
Journal:  Eur J Neurosci       Date:  2002-12       Impact factor: 3.386

Review 2.  alpha2-Adrenoceptor agonists: shedding light on neuroprotection?

Authors:  Daqing Ma; Nishanthan Rajakumaraswamy; Mervyn Maze
Journal:  Br Med Bull       Date:  2005-01-31       Impact factor: 4.291

Review 3.  Response of substances co-expressed in hypothalamic magnocellular neurons to osmotic challenges in normal and Brattleboro rats.

Authors:  Jana Bundzikova; Zdeno Pirnik; Dora Zelena; Jens D Mikkelsen; Alexander Kiss
Journal:  Cell Mol Neurobiol       Date:  2008-09-05       Impact factor: 5.046

4.  Central alpha2-receptor mechanisms contribute to enhanced renal responses during ketamine-xylazine anesthesia.

Authors:  A D Cabral; D R Kapusta; V A Kenigs; K J Varner
Journal:  Am J Physiol       Date:  1998-12

5.  Regulation of hypothalamic magnocellular neuropeptides and their mRNAs in the Brattleboro rat: coordinate responses to further osmotic challenge.

Authors:  T G Sherman; R Day; O Civelli; J Douglass; E Herbert; H Akil; S J Watson
Journal:  J Neurosci       Date:  1988-10       Impact factor: 6.167

6.  Central regulation of oxytocin release with and without vasopressin release.

Authors:  L H Aulsebrook; R C Holland
Journal:  Am J Physiol       Date:  1969-04

7.  Endogenous opioid regulation of oxytocin release during parturition is reduced in ovariectomized rats.

Authors:  S A Way; A J Douglas; S Dye; R J Bicknell; G Leng; J A Russell
Journal:  J Endocrinol       Date:  1993-07       Impact factor: 4.286

Review 8.  Pharmacological properties, central nervous system effects, and potential therapeutic applications of atipamezole, a selective alpha2-adrenoceptor antagonist.

Authors:  Antti Pertovaara; Antti Haapalinna; Jouni Sirviö; Raimo Virtanen
Journal:  CNS Drug Rev       Date:  2005

9.  Substance P and NPY differentially potentiate ATP and adrenergic stimulated vasopressin and oxytocin release.

Authors:  J R Kapoor; C D Sladek
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-01       Impact factor: 3.619

10.  Effects of alpha 2-adrenoceptor agonists on locus coeruleus firing rate and brain noradrenaline turnover in N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ)-treated rats.

Authors:  G Engberg; E Eriksson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.